Beleave and Dr. Mohit Bhandari Begin Clinical Research Program to Investigate Therapeutic Use of Cannabinoids for Musculoskeletal Disorders
26 avr. 2017 07h30 HE
|
Beleave Inc.
TORONTO, ON--(Marketwired - April 26, 2017) - Beleave Inc. ("Beleave") (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to announce that it will begin a clinical research program with Dr. Mohit...
Beleave and Ryerson University Continue Research and Development of Industrial Processes
06 mars 2017 07h00 HE
|
Beleave Inc.
TORONTO, ON--(Marketwired - March 06, 2017) - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to announce that it is now beginning work on a second drug...
Beleave and Ryerson University Collaborator Begin Patent Work by Expanding on Recent Genetic Results
08 févr. 2017 07h00 HE
|
Beleave Inc.;Ryerson University;NSERC
TORONTO, ON--(Marketwired - February 08, 2017) - Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to announce that it will begin a collaborative research project with Dr. Lesley Campbell,...
Beleave Completes Facility Build Out and Upgrades in Advance of Future Expansion
12 janv. 2017 07h30 HE
|
Beleave Inc.
TORONTO, ON--(Marketwired - January 12, 2017) - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) is pleased to announce that after receiving its affirmation letter, as announced September 26,...
Beleave and Ryerson Develop Unique Approach for Cannabinoid Extraction and Recovery
14 déc. 2016 08h27 HE
|
Beleave Inc.;Ryerson University;NSERC
TORONTO, ON--(Marketwired - December 14, 2016) - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) is pleased to announce that it has successfully completed a Natural Sciences and Engineering...
Beleave Provides Business Update
26 sept. 2016 07h30 HE
|
Beleave Inc.
TORONTO, ON--(Marketwired - September 26, 2016) - Beleave Inc. ("Beleave" or the "Company") (CSE: BE) is pleased to announce that it has received notification from Health Canada that, upon the...
Beleave Appoints Retired Lieutenant Colonel Dana Gidlow as Head of Veteran Affairs and Community Outreach
16 juin 2016 08h00 HE
|
Beleave Inc.
TORONTO, June 16, 2016 (GLOBE NEWSWIRE) -- Beleave Inc. (CSE:BE) (“Beleave” or the “Company”) is pleased to announce the addition of retired Lieutenant Colonel Dana Gidlow as the company’s Head of...
Beleave Announces the Addition of Former Drug Prosecutor Chris Murphy to the Team
15 juin 2016 08h00 HE
|
Beleave Inc.
TORONTO, June 15, 2016 (GLOBE NEWSWIRE) -- Beleave Inc. (CSE:BE) (“Beleave” or the “Company”) is pleased to announce that Chris Murphy B.A., M.A., LL.B. will be added to the...
Beleave Strengthens Advisory Board With Addition of Andrew Steane
03 mai 2016 10h54 HE
|
Beleave Inc.
TORONTO, May 03, 2016 (GLOBE NEWSWIRE) -- Beleave Inc. (CSE:BE) (“Beleave” or the “Company”) is pleased to announce that Andrew Steane will be added to the company’s Advisory Board. With over 20...
Beleave Signs Letter of Intent With gDial Inc. Regarding Proprietary Drug Dosing, Detection, and Usage-Tracking Technology
18 avr. 2016 09h05 HE
|
Beleave Inc.
TORONTO, ON--(Marketwired - April 18, 2016) -
Beleave Inc.
(CSE: BE) ("Beleave" or the "Company") is pleased to announce that it has entered into a letter of intent ("LOI") to pursue a...